Therapeutics on target:
Attacking cancer at the source


PanTher Therapeutics is a clinical-stage oncology company working to revolutionize the treatment of solid tumors.

Our minimally invasive implantable modality provides targeted and sustained localized cancer therapy, precisely directed at the intended site. 

Our mission is to revolutionize cancer care with a proprietary treatment platform designed to enhance therapeutic response with minimal side effects.
​PanTher is led by a multidisciplinary group of entrepreneurs, clinicians, researchers, engineers and business people.
Aug. 2020 - PanTher starred in documentary on Cambridge biotech industry
Nov. 2019 - PanTher honored by The National Pancreas Foundation.
  • twitter-4-xxl
  • linkedin-4-xxl
  • email-14-xxl